Avoro Capital Advisors LLC 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 09:03 am Sale | 2025-12-31 | 13G | Avidity Biosciences, Inc. RNA | Avoro Capital Advisors LLC | 8,515,792 5.540% | -1,420,000 (-14.29%) | Filing |
| 2024-11-14 09:39 am Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | Avoro Capital Advisors LLC | 9,935,792 8.300% | 9,935,792 (New Position) | Filing |